Thunderbird Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-270,095
Closed -$61.3M 9
2020
Q1
$61.3M Buy
270,095
+6,869
+3% +$1.87M 9.59% 6
2019
Q4
$79.5M Buy
+263,226
New +$72.4M 12.79% 3

Other funds holding ELV

Thunderbird Partners's ELV Position: Q2 2020 in Review

Thunderbird Partners sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 270,095 shares — an estimated $61.3M sold.

Thunderbird Partners first reported a position in ELV in Q4 2019 and held it in 2 quarters. The position peaked at $79.5M in Q4 2019. 1,106 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • Thunderbird Partners reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • Thunderbird Partners sold 270,095 Elevance Health shares in Q2 2020, an estimated $61.3M.
  • Thunderbird Partners first reported a position in Elevance Health in Q4 2019 and held it in 2 quarters.
  • Thunderbird Partners's Elevance Health position peaked at $79.5M in Q4 2019.
  • 1,106 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Thunderbird Partners's 13F filing for Q2 2020, filed 14 Aug 2020.